Shanxi Zhendong Pioneer Biotechnology

Shanxi Zhendong Pioneer Biotechnology is the dedicated innovative drug research and development arm of the Zhendong Pharmaceutical Group. Based in Shanxi, China, the company focuses on the discovery and clinical advancement of small molecule therapeutics, with a primary emphasis on oncology. Its lead program, ZD03, is a potent PARP inhibitor currently being investigated in clinical trials for the treatment of various solid tumors. The company leverages the extensive manufacturing and commercialization capabilities of its parent organization to bridge the gap between laboratory research and patient care. Zhendong Pioneer continues to expand its pipeline with candidates targeting diverse biological pathways to address high-unmet-need indications.